Glox therapeutics awarded share of £3m collaborative discovery programme funding from cystic fibrosis antimicrobial resistance syndicate

Glasgow, scotland--(business wire)-- #amr--£500k grant to accelerate development of glox therapeutics' novel precision antibiotics targeting amr lung infections in people with cystic fibrosis.

MMM Ratings Summary

MMM Quant Ranking